Avid Bioservices Inc (CDMO)

[cjgaddy]

The latest Pipeline chart shows the Bavi+Ipilimumab(BMS' Yervoy) vs. Adv.Melanoma IST progress-bar a tad into “Phase I”. Diff. from the way presented before (see below). Not sure that means it’s started yet, but it’s an IST (UTSW), and UTSW is in control of the trial itself and its reporting (to Peregrine or otherwise).



Jan.2014 Factsheet:


= = = = = = = = =
O. 6th IST Trial: Bavi+Ipilimumab(Yervoy) vs. Adv.Melanoma (Ph1b, random, open-label, 2arms, n=24)
Protocol (UTSW): http://www.clinicaltrials.gov/ct2/show/NCT01984255 => “Est Start: Mar.2014”
…Note: Ipilimumab = BMS’s “Yervoy” (anti-CTLA-4) http://www.yervoy.com